LA JOLLA, Calif., September 2, 2025 – Enlaza Therapeutics, the first covalent biologics platform company, today announced a multi-target drug discovery collaboration with Vertex Pharmaceuticals (Nasdaq: VRTX) to utilize Enlaza’s...
Art Pappas joins a Venture Capital Panel at Mid-Atlantic Bio on September 28 in Bethesda, MD.
News | 08. 20. 2012
Art Pappas joins a Venture Capital Panel at Mid-Atlantic Bio on September 28 in Bethesda, MD.
